Patient Pathfinder: Clinical Trials
Clinical Trials for Multiple Myeloma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 533 active Multiple Myeloma trials
A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis
Study Type: Interventional Phase 1
MT2017-45: CAR-T Cell Therapy for Heme Malignancies
Study Type: Observational
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
Study Type: Interventional Phase 3
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Study Type: Interventional
Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy
Study Type: Interventional
PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma
Study Type: Interventional Phase 2
A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma
Study Type: Interventional Phase 1
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
Study Type: Interventional Phase 2
There are 533 active Multiple Myeloma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now